1. Liu, Yue-Hua, Yuan, Meng, Xu, Bai-Xue, Wang, Hai-Long, Pang, Min. 2022. ANKRD49 promotes the invasion and metastasis of lung adenocarcinoma via a P38/ATF-2 signalling pathway. In Journal of cellular and molecular medicine, 26, 4401-4415. doi:10.1111/jcmm.17464. https://pubmed.ncbi.nlm.nih.gov/35775112/
2. Hao, Chunyan, Duan, Hubin, Li, Hao, Fan, Yimin, Zhang, Ce. 2017. Up-regulation of ANKDR49, a poor prognostic factor, regulates cell proliferation of gliomas. In Bioscience reports, 37, . doi:10.1042/BSR20170800. https://pubmed.ncbi.nlm.nih.gov/28694302/
3. Zhou, Xia, Wang, Wen-Tao, Sun, Jia, Guo, Rui, Wang, Hai-Long. 2019. ANKRD49 inhibits etoposide-induced intrinsic apoptosis of GC-1 cells by modulating NF-κB signaling. In Molecular and cellular biochemistry, 457, 21-29. doi:10.1007/s11010-019-03508-9. https://pubmed.ncbi.nlm.nih.gov/30798416/
4. Wang, Hai-long, Fan, Sha-sha, Pang, Min, Xie, Jun, Zheng, Guo-ping. 2015. The Ankyrin Repeat Domain 49 (ANKRD49) Augments Autophagy of Serum-Starved GC-1 Cells through the NF-κB Pathway. In PloS one, 10, e0128551. doi:10.1371/journal.pone.0128551. https://pubmed.ncbi.nlm.nih.gov/26043108/
5. Liu, Chen-Guang, Cui, Xiao-Long, Wei, Zhi-Gang, Guo, Jian-Sheng. . High expression of the ANKRD49 protein is associated with progression and poor prognosis of gastric cancer. In Cancer biomarkers : section A of Disease markers, 22, 649-656. doi:10.3233/CBM-171074. https://pubmed.ncbi.nlm.nih.gov/29865034/
6. Hsu, Yi-Chiung, Yuan, Shinsheng, Chen, Hsuan-Yu, Li, Ker-Chau, Yang, Pan-Chyr. 2009. A four-gene signature from NCI-60 cell line for survival prediction in non-small cell lung cancer. In Clinical cancer research : an official journal of the American Association for Cancer Research, 15, 7309-15. doi:10.1158/1078-0432.CCR-09-1572. https://pubmed.ncbi.nlm.nih.gov/19920108/
智鼠故事 
